Ua. Germann et al., PUTATIVE MDR-ENHANCER IS LOCATED ON HUMAN-CHROMOSOME-20 AND NOT LINKED TO THE MDRI GENE ON CHROMOSOME-7, Genes, chromosomes & cancer, 10(4), 1994, pp. 267-274
The physiologic expression of the human multidrug resistance MDR1 gene
product P-glycoprotein is controlled in a tissue- and cell-specific m
anner, but the regulatory mechanisms have not been characterized in gr
eat detail. Studies by Kohno et al. [(1990) Biol Chem 265: 19690-19696
] suggested that a tissue-specific enhancer element located approximat
ely 10 kb upstream from the major MDR I transcription start site may a
ct to increase the levels of transcription in cultured adrenal and kid
ney cells. Using this putative ''MDR enhancer'' as a probe, we isolate
d a 14 kb DNA fragment from a genomic DNA library prepared from human
fetal liver. The restriction map and partial nucleotide sequence of th
is DNA fragment were consistent with the previously described data obt
ained for a similar piece of genomic DNA derived from human placenta b
y Kohno et al. (ibid.). pulsed-field gel electrophoresis of large geno
mic DNA fragments, however, showed that the DNA sequences, including t
he putative ''MDR enhancer,'' were not linked to the MDR1 gene. Fluore
scence in situ hybridization analysis revealed that this enhancer-like
element is located on chromosome 20 at band q13.1 and is, therefore,
distinct from the MDR locus on chromosome 7, band q21.1. Thus, this pu
tative regulatory element does not modulate the tissue specificity of
expression of the MDR1 gene in vivo, but may play a role in the regula
tion of expression of another, so far unknown gene. Genes Chromosom Ca
ncer 10:267-274 (1994). (C) 1994 Wiley-Liss, Inc.